Humanized antibody shows strong neutralization ability against SARS-CoV-2 Delta variant
Researchers combine SARS-CoV-2 spike vaccination with single-cell B-cell receptor sequencing technology to discover neutralizing antibody candidates.
Source: news-medical.net